Sage Journals: Discover world-class research

Open access

Case report

First published 2024-9

New onset lymphopenia in patients with relapsing multiple sclerosis switching from long-standing dimethyl fumarate treatment to diroximel fumarate: A case series

Megan Schneider, John Kramer, Aimee Banks [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2020-11

Diroximel fumarate (DRF) in patients with relapsing–remitting multiple sclerosis: Interim safety and efficacy results from the phase 3 EVOLVE-MS-1 study

Robert T Naismith, Jerry S Wolinsky, Annette Wundes [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2021

Improved gastrointestinal profile with diroximel fumarate is associated with a positive impact on quality of life compared with dimethyl fumarate: results from the randomized,double-blind,phase III EVOLVE-MS-2 study

Annette Wundes, Sibyl Wray, Ralf Gold [...]

Therapeutic Advances in Neurological Disorders

Open access

Research article

First published 2023-12

Diroximel fumarate in patients with relapsing–remitting multiple sclerosis: Final safety and efficacy results from the phase 3 EVOLVE-MS-1 study

Barry A Singer, Douglas L Arnold, Jelena Drulovic [...]

Multiple Sclerosis Journal

Open access

Review article

First published 2023-7

Vaccine response in people with multiple sclerosis treated with fumarates

Matthew A. Tremblay, Sandra Vukusic, Mathura Shanmugasundaram [...]

Multiple Sclerosis Journal – Experimental,Translational and Clinical

Retricted access

Research article

First published 2025-4

Severe gastrointestinal adverse reactions including perforation,ulceration,hemorrhage,and obstruction: A fumaric acid ester class new safety risk

Tiffany Kim, Allen Brinker, David Croteau [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2024

Treatment switches of disease-modifying therapies in people with multiple sclerosis: long-term experience from the German MS Registry

Niklas Frahm, David Ellenberger, Alexander Stahmann [...]

Therapeutic Advances in Neurological Disorders

Open access

Research article

First published 2025

Cellular and humoral vaccination response under immunotherapies—German consensus on vaccination strategies in neurological autoimmune diseases

Muriel Schraad, Mathias Mäurer, Anke Salmen [...]

Therapeutic Advances in Neurological Disorders

Search results